Sanomed
Sanomed is a Bratislava-based pharmaceutical distributor founded in 2011 that markets and sells branded medical devices and supplements across Central and Eastern Europe via its own e-commerce site and pharmacy chains such as Dr.Max and BENU.
- Company typePrivate
- Founded2011
- HeadquartersBratislava
- Headcount1–10
- GTM typeB2C
- OfferingHardware or Manufacturing
What Sanomed does
Sanomed (SANOMED s.r.o.) is a Bratislava-based pharmaceutical marketing and distribution company founded in 2011 that operates in Central and Eastern Europe. The company sells a portfolio of branded medical devices and dietary supplements covering therapeutic areas including neurology (NurAiD II for brain regeneration), gynecology (DIKIROGEN ZERO for PCOS, Sérélys MENO for menopause), urology (Sérélys INCO), dermatology (K5 Lipogel, RECREOL), and oncology support (Iside HPV). Products are positioned primarily as consumer-health and post-acute recovery aids, often with clinical content targeted at specific patient populations.
The company operates a dual-channel go-to-market. Wholly-owned e-commerce at sanomed.sk serves direct-to-consumer demand across Slovakia, Czechia, and English-speaking CEE markets, with the storefront available in Slovak, Czech, and English. Wholesale distribution is conducted through major retail pharmacy chains including Dr.Max and BENU, providing physical-shelf access to a broad consumer base. The company is a private limited company (s.r.o.), reports 1–10 employees, has no disclosed external funding, and has no parent entity. No revenue, ARR, or unit-volume figures are publicly disclosed.
Sanomed's business model is brand-and-distribution-led: it markets and distributes finished medical devices and supplements under proprietary trademarks, with pricing observed in the range of roughly €11 to €590 per SKU. The model relies on retail pharmacy shelf placement, DTC e-commerce, and content marketing (notably an extensive blog on stroke recovery) to drive awareness. There is no visible AI/ML technology stack, no enterprise customer base, and no third-party investor signaling. The strategic posture is that of a small, niche CEE distributor extending its portfolio reach across multiple therapeutic verticals.
Sanomed firmographics
Firmographics- Name
- Sanomed
- Legal name
- SANOMED s.r.o.
- Website
- https://sanomed.sk
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Sanomed is a Bratislava-based pharmaceutical distributor founded in 2011 that markets and sells branded medical devices and supplements across Central and Eastern Europe via its own e-commerce site and pharmacy chains such as Dr.Max and BENU.
- Ownership category
- akta.pro rank
Sanomed industry classification
Industry- Product category
- Pharmaceutical Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421), Pharmacies and Drug Retailers (456110)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Women’s Health & Reproductive Specialty Pharmaceuticals (HLAIACAN)
- akta.pro secondary industries
- Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Nephrology & Urology Pharmaceuticals (HLAIAAAM)
Keywords
Where Sanomed is headquartered
LocationHeadquarters
- HQ city
- Bratislava
Offices1 record
Markets served
Sanomed business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Marketing or Sales, Operations, Personnel, Technology or R&D
Revenue model
- Pharmaceutical Product Sales: SANOMED generates revenue by marketing and distributing a wide portfolio of pharmaceutical products including nutraceuticals, medical devices, and supplements across multiple therapeutic areas (gynecology, neurology, dermatology, gastroenterology, diagnostics) in Central and Eastern European markets since 2011.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Multi-year contract | NurAiD II - 180 capsules |
| Subscription | Monthly | Standard Pricing |
| Unit Pricing | One time/ perpetual license | K5 Lipogel promotional price |
| Unit Pricing | One time/ perpetual license | DIKIROGEN ZERO |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels3 records
Sanomed product offering
Product offeringCore offering
Sanomed markets and distributes a portfolio of branded pharmaceutical products — including nutraceuticals, medical devices, and dietary supplements — across gynecology, neurology, dermatology, gastroenterology, and diagnostics for the Central and Eastern European market. Products include the NurAiD II brain regeneration supplement, DIKIROGEN ZERO for PCOS/infertility, Sérélys INCO for bladder function, Sérélys MENO for menopause, Iside HPV vaginal suppositories, and K5 Lipogel depigmenting cream. Sales occur through the company's own e-commerce platform (sanomed.sk) and through pharmacy distribution networks.
Product overview
Sanomed is a pharmaceutical and marketing company operating in Central and Eastern Europe since 2011, offering a portfolio of healthcare products including nutritional supplements, medical devices, and dermatological products. Their therapeutic areas include gynecology (Iside HPV, DIKIROGEN ZERO, Sérélys INCO, Sérélys MENO), dermatology (K5 Lipogel, RECREOL, Frest), neurology/brain health (NurAiD II for stroke and brain injury recovery), gastroenterology, and diagnostics. The company positions itself as a distributor bringing safe and effective medicines to patients while serving as a partner for healthcare industry clients.
Differentiator
Problem solved
Functional benefit
Brands
- NurAiD II: A verified and safe product composed of 9 plant ingredients that helps people after stroke, traumatic brain injury, and spinal cord injury regain independence in activities of daily living
- DIKIROGEN ZERO
- Sérélys INCO
- Sérélys MENO
- K5 Lipogel
- Iside HPV
Products and services
- NurAiD II (NURAID PACK) A clinically verified product composed of 9 plant-based ingredients (MLC901 formula) in 180-capsule packages, designed to support natural brain regeneration in patients after stroke, traumatic brain injury, spinal cord injury, and Alzheimer's disease, helping regain independence in activities of daily living.
- Iside HPV Vaginal suppositories containing PrincipHYAL® (full-spectrum sodium hyaluronic acid), lactic acid, citric acid, arabinogalactan, and zinc citrate to support cervical health, vaginal mucosa regeneration, and natural defense mechanisms in women with HPV infection.
- DIKIROGEN ZERO A sugar-free nutritional supplement based on myo-inositol, D-chiro-inositol, folic acid, and manganese, sold in packages of 30 sachets, designed for supportive therapy of metabolic and reproductive disorders, particularly polycystic ovary syndrome (PCOS) and infertility.
- Sérélys INCO A natural, non-hormonal supplement without phytoestrogenic activity for urinary incontinence. Contains UriCyTonin® (rye pollen extract), pumpkin seed extract, and Vitamin E to help maintain healthy bladder function in adults, with clinical study support.
- Sérélys MENO A clinically verified, non-hormonal supplement containing PureCyTonin® PI & GC purified pollen cytoplasm extracts and Vitamin E, designed for menopausal comfort including thermoregulation (hot flashes), sleep improvement, and mood support during perimenopause and menopause.
- K5 Lipogel A gently perfumed, allergen-free depigmenting lipogel cream for brown spots on the face, neck, and hands, sold at €11 per unit (promo) and providing rapid, effective whitening for skin pigmentation disorders.
- RECREOL A dermatological product listed under the dermatology category of the Sanomed e-shop, distributed alongside K5 Lipogel and Frest.
- Frest A dermatological product listed under the dermatology category of the Sanomed e-shop.
- K5 A dermatological product listed under the dermatology category of the Sanomed e-shop.
Quantifiable outcome
- DIKIROGEN ZERO shown to improve menstrual cycle regularity from 53 to 33 days and reduce women with irregular cycles from 63.5% to 23.1% in 6-month study of 104 women with PCOS
- +2 more outcomes
Companies that use Sanomed
Customer profileSegments4 records
Ideal customer profiles4 records
Sanomed technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Sanomed partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Pharmaceutical Distribution CompaniescoreSANOMED maintains over-standard business relationships with multiple distribution companies for pharmaceutical product distribution across Central and Eastern Europe.
- PharmaciescorePartnership network with pharmacies for product availability and distribution to end consumers.
- Healthcare FacilitiescoreBusiness relationships with healthcare facilities for product distribution and professional collaboration in healthcare sector.
- Professional Medical SocietiesminorCollaboration with professional medical societies for product development and market positioning.
- Medical DoctorsminorRelationships with doctors for product recommendations and healthcare provision to patients.
Scale indicators2 records
Recent moves5 records
Expansion highlights5 records
Sanomed competitors and assessment
Company assessmentDirect peers
- KRKA: KRKA is a Slovenian pharmaceutical company marketing branded generic and specialty products across CEE, Eastern Europe, and beyond—comparable to Sanomed's CEE-focused distribution model and multi-therapeutic portfolio strategy.
- STADA Arzneimittel: STADA is a European-focused generics and specialty pharma company with strong CEE distribution through pharmacy channels, closely comparable to Sanomed's pharmacy-driven distribution model in the region.
- Gedeon Richter: Gedeon Richter is a Hungarian-headquartered pharmaceutical company with a significant women's health and CNS portfolio, comparable to Sanomed's emphasis on gynecological and neurology products across CEE markets.
- PHOENIX Group: PHOENIX Group is a leading European pharmaceutical wholesaler with strong presence in CEE markets, comparable to Sanomed's wholesale/pharmacy distribution business model but at substantially larger scale.
- Zentiva: Zentiva is a Czech-headquartered pan-European pharmaceutical manufacturer and distributor with deep CEE presence, comparable to Sanomed's distribution and marketing focus across Central and Eastern Europe, though at far larger scale and with broader branded/generic portfolio.
Emerging players
- Theramex: Theramex is a global specialty pharma company focused exclusively on women's health, comparable to Sanomed's over-indexed focus on gynecology, menopause, and reproductive health products.
- Exeltis: Exeltis is a specialty pharmaceutical company focused on women's health and CNS products across Europe, comparable to Sanomed's Sérélys and DIKIROGEN women's health franchise and CEE commercialization approach.
Broad incumbents
- Teva Pharmaceutical Industries: Teva is a global generics and specialty pharma leader with CEE presence, providing a broad incumbent benchmark for the pharmaceutical distribution and marketing model Sanomed operates, though at vastly larger scale and scope.
- Dr. Max: Dr. Max is the largest pharmacy chain in Central Europe and a key distribution partner for Sanomed's products; while it operates as a retailer rather than a competitor, its scale and CEE footprint make it a highly relevant comparable for the CEE pharma distribution market.
- Alliance Healthcare: Alliance Healthcare is a major European pharmaceutical wholesale and distribution business serving independent pharmacies, comparable to Sanomed's pharmacy-led distribution model though with significantly broader geographic and product scope.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat2 records
Key risks6 records
Key highlights7 records
Customer concentration
Sanomed social profiles
Digital presenceSanomed financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sanomed leadership team
Management profileNumber of profiles
Sanomed funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sanomed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sanomed
What does Sanomed do?
Sanomed markets and distributes a portfolio of branded pharmaceutical products — including nutraceuticals, medical devices, and dietary supplements — across gynecology, neurology, dermatology, gastroenterology, and diagnostics for the Central and Eastern European market. Products include the NurAiD II brain regeneration supplement, DIKIROGEN ZERO for PCOS/infertility, Sérélys INCO for bladder function, Sérélys MENO for menopause, Iside HPV vaginal suppositories, and K5 Lipogel depigmenting cream. Sales occur through the company's own e-commerce platform (sanomed.sk) and through pharmacy distribution networks.
Is Sanomed a public or private company?
Sanomed is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Sanomed founded?
Sanomed was founded in 2011. It employs 1 to 10 people.
Where is Sanomed based?
Sanomed is headquartered in Bratislava.
How does Sanomed make money?
One revenue line is on record: pharmaceutical Product Sales.
Who are Sanomed's main competitors?
Direct peers on record are KRKA, STADA Arzneimittel, Gedeon Richter, PHOENIX Group and Zentiva. Emerging players are Theramex and Exeltis. Broad incumbents are Teva Pharmaceutical Industries, Dr. Max and Alliance Healthcare.
Does Sanomed have an API?
No public API is recorded for Sanomed.
What industry is Sanomed in?
Sanomed's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLAIACAN, Women’s Health & Reproductive Specialty Pharmaceuticals, with a secondary code of HLAIAAAJ, Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health). Its NAICS code is 42421 and its SIC code is 2834.